Contemporary Outcomes of Acute Limb Ischemia Endovascular Revascularization

Acute limb ischemia (ALI) is a vascular emergency with high mortality rate. It has been defined as a sudden occlusion of limb perfusion compromising its viability. It is most frequently caused by an embolism followed by in situ thrombosis. Even though ALI incidence has recently declined, it is still high, affecting close to 1.5 patients every 10,000 persons. 

Resultados actuales del tratamiento endovascular de la isquemia arterial aguda

This condition has been associated to higher risk of major cardiac events, amputation and death driving the advance of revascularization techniques, which increased endovascular revascularization cases over 100% of since 2003 until 2011. The evidence suggests endovascular revascularization presents lower complications rates without increased amputation risk vs. surgical revascularization. 

Study Objective

The study aimed at assessing ALI endovascular revascularization outcomes using a multicenter registry, in addition to identifying mortality and amputation risk factors after endovascular revascularization. 

Read also: TCT 2024 | TRISCEND II: A New Hope in Percutaneous Tricuspid Valve Replacement.

End Points

Primary end point was a combined event of death and unplanned amputation during hospitalization while secondary end point was comprised of the individual primary end point components. 

Results

3,541 patients were included, mean age 66, mostly men. There were 132 deaths (3.7%) and 77 amputations (2.2%) during hospitalization. Thrombolysis catheters were used in 27.7% (n = 981) of cases and mechanical thrombectomy catheters in 3.9% (n = 138) of cases. Independent predictors of death or amputation were severe lung disease (OR: 1.72; DI 95%: 1.17-2.52), Rutherford class IIb (OR: 2.44; CI 95%: 1.62-3.65), terminal kidney disease (OR: 3.94; IC 95%: 0.73-0.85) and pre-procedural hemoglobin levels (OR: 0.78; CI 95%: 0.73-0.85). Main complications were bleeding within the first 72 hrs. after intervention (6.7%) and thrombosis (2.8%).

Conclusión 

This study on ALI endovascular revascularization offers valuable information on factors influencing adverse results in these patients. Adverse events predictors are mainly associated to patient characteristics, which might be useful for risk stratification and prognosis. Further studies are required to identify what patients might benefit from endovascular revascularization. 

Original Title: Contemporary Practice Patterns and Outcomes of Endovascular Revascularization of Acute Limb Ischemia.

Reference: Matthew S. Herzig, MD et al JACC Cardiovasc Interv. 2024;17:2379–2390.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Andrés Rodríguez
Dr. Andrés Rodríguez
Member of the Editorial Board of solaci.org

More articles by this author

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Chronic Thromboembolic Pulmonary Hypertension: Treatment Outcomes According to a Worldwide Registry

Chronic thromboembolic pulmonary hypertension (CTEPH) is a highly limiting condition that, despite its moderate incidence, significantly impacts patient prognosis and quality of life. The...

TCT 2024 | SIRONA: Randomized Study Comparing Sirolimus-Coated vs Paclitaxel-Coated Balloon Angioplasty in Femoropopliteal Disease

This prospective, randomized, multicenter, investigator-initiated non-inferiority study compared the use of sirolimus-coated balloon (MagicTouch) vs paclitaxel-coated balloon in endovascular treatment.  The primary objective was to...

TCT 2024 | PEERLESS: Mechanical Thrombectomy with FlowTriever vs Catheter-Directed Thrombolysis in Intermediate Risk PTE

Pulmonary embolism (PE) continues to be the third cause of cardiovascular mortality. The current clinical guidelines recommend anticoagulation in intermediate risk patients presenting right...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...